My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.

    Labonté ED, Kirby RJ, Schildmeyer NM, Cannon AM, Huggins KW, Hui DY.

    Diabetes. 2006 Apr;55(4):935-41.PMID: 16567514 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice.

    Hui DY, Cope MJ, Labonté ED, Chang HT, Shao J, Goka E, Abousalham A, Charmot D, Buysse J.

    Br J Pharmacol. 2009 Aug;157(7):1263-9. Epub 2009 Jun 25.PMID: 19563529 [PubMed - in process]Related articles

    3.

    Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

    Eckey R, Menschikowski M, Lattke P, Jaross W.

    Inflammation. 2004 Apr;28(2):59-65.PMID: 15379211 [PubMed - indexed for MEDLINE]Related articles

    4.

    Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A(2)-deficient mice.

    Richmond BL, Boileau AC, Zheng S, Huggins KW, Granholm NA, Tso P, Hui DY.

    Gastroenterology. 2001 Apr;120(5):1193-202.PMID: 11266383 [PubMed - indexed for MEDLINE]Related articles

    5.

    Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.

    Yamazaki K, Inoue T, Yasuda N, Sato Y, Nagakura T, Takenaka O, Clark R, Saeki T, Tanaka I.

    J Pharmacol Sci. 2007 May;104(1):29-38. Epub 2007 May 8.PMID: 17485917 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.

    Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R.

    Diabetes. 2006 Dec;55(12):3536-49.PMID: 17130502 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Improved glucose metabolism in mice lacking alpha-tocopherol transfer protein.

    Birringer M, Kuhlow D, Pfluger PT, Landes N, Schulz TJ, Glaubitz M, Florian S, Pfeiffer A, Schuelke M, Brigelius-Flohé R, Ristow M.

    Eur J Nutr. 2007 Oct;46(7):397-405. Epub 2007 Sep 19.PMID: 17882348 [PubMed - indexed for MEDLINE]Related articles

    8.

    Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.

    Wu C, Khan SA, Peng LJ, Li H, Carmella SG, Lange AJ.

    Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E536-43. Epub 2006 Apr 18. Erratum in: Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E370. PMID: 16621898 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.

    Kirkman MS, Shankar RR, Shankar S, Shen C, Brizendine E, Baron A, McGill J.

    Diabetes Care. 2006 Sep;29(9):2095-101.PMID: 16936159 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.

    Bao S, Song H, Wohltmann M, Ramanadham S, Jin W, Bohrer A, Turk J.

    J Biol Chem. 2006 Jul 28;281(30):20958-73. Epub 2006 May 27.PMID: 16732058 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1.

    Okamoto Y, Ogawa W, Nishizawa A, Inoue H, Teshigawara K, Kinoshita S, Matsuki Y, Watanabe E, Hiramatsu R, Sakaue H, Noda T, Kasuga M.

    Diabetes. 2007 Apr;56(4):1000-9. Epub 2007 Jan 31.PMID: 17267763 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hepatic nonoxidative disposal of an oral glucose meal in patients with liver cirrhosis.

    Schneiter P, Gillet M, Chioléro R, Jéquier E, Tappy L.

    Metabolism. 1999 Oct;48(10):1260-6.PMID: 10535388 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice.

    Hofmann SM, Zhou L, Perez-Tilve D, Greer T, Grant E, Wancata L, Thomas A, Pfluger PT, Basford JE, Gilham D, Herz J, Tschöp MH, Hui DY.

    J Clin Invest. 2007 Nov;117(11):3271-82.PMID: 17948131 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.

    Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.

    Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1687-96. Epub 2007 Oct 2.PMID: 17911348 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.

    Singh V, Grötzinger C, Nowak KW, Zacharias S, Göncz E, Pless G, Sauer IM, Eichhorn I, Pfeiffer-Guglielmi B, Hamprecht B, Wiedenmann B, Plöckinger U, Strowski MZ.

    Endocrinology. 2007 Aug;148(8):3887-99. Epub 2007 May 24.PMID: 17525126 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.

    Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, Musi N, DeFronzo RA, Cersosimo E.

    Am J Physiol Endocrinol Metab. 2008 May;294(5):E846-52. Epub 2008 Mar 11.PMID: 18334612 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.

    Hashimoto H, Arai T, Takeguchi A, Hioki K, Ohnishi Y, Kawai K, Ito M, Suzuki R, Yamauchi T, Ohsugi M, Saito M, Ueyama Y, Tobe K, Kadowaki T, Tamaoki N, Kosaka K.

    Comp Med. 2006 Jun;56(3):176-87.PMID: 16774126 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Postprandial hyperglycemia and diabetic complications]

    Da Ros R, Assaloni R, Ceriello A.

    Recenti Prog Med. 2005 Sep;96(9):436-44. Review. Italian. PMID: 16229326 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.

    Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.

    Scand J Clin Lab Invest. 2007;67(3):327-36.PMID: 17454847 [PubMed - indexed for MEDLINE]Related articles

    20.

    Early and rapid development of insulin resistance, islet dysfunction and glucose intolerance after high-fat feeding in mice overexpressing phosphodiesterase 3B.

    Walz HA, Härndahl L, Wierup N, Zmuda-Trzebiatowska E, Svennelid F, Manganiello VC, Ploug T, Sundler F, Degerman E, Ahrén B, Holst LS.

    J Endocrinol. 2006 Jun;189(3):629-41.PMID: 16731793 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity